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Donald R Royall1,2,3,4*, Ricardo Salazar1 and Raymond F Palmer3Abstract
Background: Unobserved “latent” variables have the potential to minimize “measurement error” inherent to any
single clinical assessment or categorical diagnosis.
Objectives: To demonstrate the potential utility of latent variable constructs in pain’s assessment.
Design: We created two latent variables representing depressive symptom-related pain (Pd) and its residual, “somatic”
pain (Ps), from survey questions.
Setting: The Hispanic Established Population for Epidemiological Studies in the Elderly (H-EPESE) project, a longitudinal
population-based cohort study.
Participants: Community dwelling elderly Mexican-Americans in five Southwestern U.S. states. The data were collected
in the 7th HEPESE wave in 2010 (N = 1,078).
Measurements: Self-reported pain, Center for Epidemiological Studies Depression Scale (CES-D) scores, bedside
cognitive performance measures, and informant-rated measures of basic and instrumental Activities of Daily Living.
Results: The model showed excellent fit [χ2 = 20.37, DF = 12; p = 0.06; Comparative fit index (CFI) = 0.998; Root mean
statistical error assessment (RMSEA) = 0.025]. Ps was most strongly indicated by self-reported pain-related physician visits
(r = 0.48, p ≤0.001). Pd was most strongly indicated by self-reported pain-related sleep disturbances (r = 0.65, p <0.001).
Both Pd and Ps were significantly independently associated with chronic pain (> one month), regional pain and
pain summed across selected regions. Pd alone was significantly independently associated with self-rated health, life
satisfaction, self-reported falls, Life-space, nursing home placement, the use of opiates, and a variety of sleep related
disturbances. Ps was associated with the use of NSAIDS. Neither construct was associated with declaration of
a resuscitation preference, mode of resuscitation preference declaration, or with opting for a “Do Not Resuscitate”
(DNR) order.
Conclusion: This analysis illustrates the potential of latent variables to parse observed data into “unbiased” constructs
with unique predictive profiles. The latent constructs, by definition, are devoid of measurement error that affects any
subset of their indicators. Future studies could use such phenotypes as outcome measures in clinical pain
management trials or associate them with potential biomarkers using powerful parametric statistical methods.
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The experience of pain is a complex mental phenomenon
only partly explained by physical injury or dysfunction.
Its assessment can be challenging to clinicians, especially
in the elderly, cognitively impaired persons, and minority
populations. Cultural bias, emotional state, including* Correspondence: royall@uthscsa.edu
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reproduction in any medium, provided the oranxiety and/or depression, and cognitive resources all con-
tribute to pain’s perception and behavioral manifestations.
Dementia and depression are likely to influence pain’s
report in multiple ways. Both conditions have been
recently associated with functional central nervous sys-
tem (CNS) connectivity, especially in the Default Mode
Network (DMN) [1]. The DMN is involved in a variety of
self-reported tasks and may mediate self-awareness [2].
DMN connectivity is diminished in Alzheimer’s disease
(AD), even at pre-clinical stages [3], and abnormally in-
creased in major depression [4,5]. This may explain the
poor correlations between cognitive performance and paintd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Variables used for SEM model (n = 1079, missing
n = 69)
Indicators
CES-D (Mean/SD) 10.7 (9.2)
Pain restricted daily
activities in last 12
months? (PADL)
% “A lot” 17.6%
% “Some” 23.7%




Taking Medication for Pain? (PMED)
% “Yes” 37.6%
Pain restricted sleep in last 12 months (PSLP)
% “A lot” 7.5%
% “Some” 17.5
% “Not at all” 75%
Covariates
Number of pain medications (NpainRx)
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pressive states [6].
We recently developed a novel latent variable ap-
proach to address the similar challenges to cognition’s
assessment. Using a structural equation modeling (SEM)
approach, we explicitly distinguish “dementia-relevant”
variance in observed clinical and physiological measures
from variance in the observed data that is unrelated to
dementia [7]. Latent variable assessment offers many
potential advantages over traditional diagnostic methods
[8]. First, composite factor scores extracted from the
latent variable’s factor loadings can be used as continu-
ously distributed phenotypes. This allows us effectively
to rank order individual cases along a syndrome’s con-
tinuum and to use powerful parametric statistical methods
to find the constructs’ biomarkers. Second, the resulting
clinical phenotypes are arguably free of cultural, linguistic
or educational bias.
A further advantage of our approach is that the latent
variables are modular, and easily adapted to other clin-
ical problems. In this analysis, we use SEM to parse the
observed variance in self-reported pain complaints into
two compartments: Depressive symptom-related pain
(Pd) and “Somatic” pain (Ps). Future studies may be able
to test the biomarkers of these constructs and/or use
them as outcomes in pharmacological studies of pain’s
management.
Methods
The data were collected in Wave 7 of the Hispanic
Established Population for the Epidemiological Study
of the Elderly (H-EPESE) study. The institutional re-
view board of the University of Texas Medical Branch at
Galveston, Texas approved the H-EPESE project. All in-
dividuals discussed the study with trained research staff
and provided written informed consent.
Participants
The H-EPESE cohort was originally established ca
1993–94 with a representative sample of 3,050 Mexican
Americans aged 65 and over and residing in five
Southwestern states (i.e., Texas, New Mexico, Colorado,
Arizona, and California). These subjects were re-examined
in 1995–96 (N = 2438), 1998–99 (N = 1980), 2000–01
(N = 1683), and 2004–05 (N = 1167). An additional 902
Mexican Americans aged 75 and over were added in
2004–05. The combined sample of 2067 was followed up
approximately 2 ½ years later during 2007 (N = 1,542 sub-
jects then aged 78 and over). Data was collected on the 7th
wave in 2010 (N = 1,078). An 8th wave of follow-up is
currently in progress. In recent waves, investigators have
contacted and interviewed in-person a close family mem-
ber, usually an adult child, to detail participants’ current
health care needs and family and financial situations.Clinical variables
The H-EPESE Manual of Procedures is updated at each
Wave. All procedures are available in Spanish translation.
A. Pain: Pain was assessed by subject self-report. Table 1
lists the specific pain assessments employed, including:
Has pain restricted your daily activities in last 12
months? (PADL); Have you seen a doctor about pain?
(PMD); Are you taking medication for pain? (PMED);
and How much has pain interfered with your sleep in
last 12 months? (PSLP). PADL and PSLP were assessed
on a three point Likert Scale ranging from “A
lot” to “Not at all”. PMD and PMED were assessed
dichotomously as “Yes” or “No”.
B. Physical Function: Functional status in the H-EPESE
is assessed using measures of Basic Activities of
Daily Living (BADL) [9] and Instrumental Activities
of Daily Living (IADL) [10].
C. Cognition and Mood: The main assessment of
cognitive status employed in the H-EPESE has been
the Mini-Mental State Exam (MMSE) [11].
Table 2 Characteristics of the wave 7 HEPESE sample
(N = 1,078)
Age (mean/SD) 85.6 (4.01)
Female (%) 65
US Born (%) 54.3
Interview in Spanish (%) 81.8
Married (%) 31.4
Live Alone (%) 30.3
Annual Income < $10,000 (%) 35.1
Medicare insured (%) 96.7
Body Mass Index (mean/SD) 27.5 (5.6)
MMSE Score (mean) 21.2 (7.5)
Any BADL Impairment (%) 49.5
Any IADL Impairment (%) 85.7
Health Conditions




Hip fracture (%) 7.1
Arthritis (ever;%) 65.9
Pain or discomfort (In the past month;%) 84.2
Hypertension (Self-report & measured;%) 74.1
Number of Pain Medications (Mean/SD) 0.37 (0.56)
Interview Type 83.1
In Person Interview (%)
Assisted Proxy (%) 7.7
Proxy (%) 9.2
BADL = Basic Activities of Daily Living; CES-D = Center for Epidemiological
Studies-Depression scale; H-EPESE = Hispanic Established Population for
Epidemiological Studies in the Elderly; IADL = Instrumental Activities of Daily
Living; MMSE = Mini-Mental State Exam; US = United States.
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CLOX: An Executive Clock-Drawing Task) [12]. In
wave 7 the Neuropsychiatric Inventory (NPI) [13]
was added. The Center for Epidemiologic Studies
Depression scale (CES-D) [14] is available at all Waves.
D. Living Arrangements: At each wave H-EPESE
obtains a complete census of all individuals living
in the household including their relationship to
the subject and all subjects are traced to nursing
homes or assisted living sites using an abbreviated
questionnaire.
E. Health Care Service Utilization: H-EPESE collects
information on health care service utilization [15].
Respondents who reported having been diagnosed
with cardiovascular problems, stroke, and cancer are
also asked about hospitalizations related specifically
to those problems.
F. Medical Conditions: H-EPESE includes self-reported/
informant rated measures of chronic medical
conditions, including hypertension, diabetes, cancer,
heart disease, stroke, hip fracture, arthritis, urinary
and bowel incontinence, and other problems.
G. Anthropometric measures: Obesity is measured by
body mass index (BMI), and waist circumference.
Specific clinical assessments
CLOX: An Executive Clock-Drawing Task) [12]: CLOX
is a two-part clock-drawing task divided into a non-
prompted “executive” version (CLOX1) and a prompted
“constructional” version (CLOX2). Both tasks are scored
on the same 15 point metric. Thresholds for “impairment”
are set to young adult norms at CLOX1 = 10/15 and
CLOX2 = 12/15. Using these thresholds, a CLOX rated
“dementia-type” can be estimated [16].
The Center for Epidemiologic Studies Depression scale
(CES-D) [14]: The CES-D has been used extensively with
older populations [17], including Mexican Americans [18].
It is typically used as a continuous variable measuring
depressive symptomatology or psychological distress or as
a dichotomous variable with a score of 16+ indicating high
levels of depressive symptomatology and suggesting pos-
sible clinical depression.
The Mini-Mental Status Exam (MMSE) [11]: The
MMSE is a well known and widely used test for screening
cognitive impairment [19]. Scores range from 0 to 30.
Scores less than 24 reflect cognitive impairment.
The Neuropsychiatric Inventory (NPI) [13]: The NPI
assesses ten behavioral disturbances occurring in dementia
patients: delusions, hallucinations, dysphoria, anxiety,
agitation/aggression, euphoria, disinhibition, irritability/
lability, apathy, and aberrant motor activity. The NPI
uses a screening strategy to minimize administration time,
examining and scoring only those behavioral domains
with positive responses to screening questions. Boththe frequency and the severity of each behavior are deter-
mined. Information for the NPI is obtained from an
informant who is familiar with the subject’s behavior.
Descriptive statistics are presented in Table 2. The
Wave 7H-EPESE sample is elderly (mean age 85.7 years)
and poorly educated (mean 5.0 years of formal education).
There is a slight female majority. 54.3% were U.S. born.
81.8% were interviewed in Spanish. 35.1% of respondents
reported an annual income < $10,000.
On average, the H-EPESE sample is characterized by
low normal cognitive performance, given their advanced
age, and low educational attainment. Of the 1078 re-
spondents, 224 (20.8%) scored < 18/30 on the MMSE,
i.e., below its recommended threshold for cognitive
impairment in this demographic [20]. The cohort ex-
hibited a subsyndromal depressive symptom burden
on the CES-D. 146 respondents (13.5%) scored above a
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high fraction of subjects report potentially significant med-
ical problems, including heart attack (10%) stroke (10.6%),
cancer (10.6%), diabetes (36.5%), hip fractures (7.1%) arth-
ritis (65.9%) or hypertension (74.1%).
Statistical analysis
The descriptive statistical analysis was performed in
STATISTICA, version 10 for Windows (Statsoft, Inc.,
Tulsa, OK, U.S— www.statsoft.com). SEM analysis was
performed using Analysis of Moment Structures (AMOS)
[21]. Data were fit to a two factor latent variable model
(see Figure 1) and compared to a single factor model with
four pain items and one depression item as indicators of
the latent variable. The bi-factor model uses CES-D scores
as the “target” indicator of a second factor. This effectivelyFigure 1 Latent variables Pd and Ps*. CES-D = Centers for
Epidemiological Studies-Depression scale; CFI = Comparative Fit
Index; DF = degrees of freedom; H-EPESE = Hispanic Established
Population for Epidemiological Studies in the Elderly; PADL = self
reported pain-related functional limitations; Pd = depression-related
pain report; PMD = self reported pain-related doctor visits; PMED = self
reported pain-related medication use; Ps = somatic-related pain report;
RMSEA = Root Mean Statistical Error Assessment; PSLP = self-reported
pain-related sleep disturbance. *All observed variables are adjusted for
age, gender, the number of prescribed pain medications, Mini-mental
State Exam scores, body mass index, living alone and adequacy of
monthly financial support (covariates not shown for clarity).parses the variance shared across the pain indicators into
to factors. The first represents the variance shared with de-
pressive symptoms (i.e., “Pd”). The second represents the
shared variance that is explicitly not shared with depressive
symptoms. We interpreted this as “somatic” pain (i.e., “Ps).
This approach is modular. Any alternative target indicator
can be substituted for CES-D scores in Figure 1 and the
variance shared across the pain indicators would be parsed
again.
The latent variables were scaled by fixing the means to
0 and the variances at 1, with all loadings freely esti-
mated. Residual variances were uncorrelated with one
exception. The residual covariance between pain restricting
daily activities (PADL) and taking medication related to
pain (PMD) was estimated based on modification indi-
ces in AMOS. This significantly improved model fit
and is theoretically reasonable. Parameter estimation
was obtained by maximum likelihood. The two latent
variables (Pd and Ps) were extracted. Seven covariates: age,
gender, income, number of pain medications, living alone
status, Body Mass Index (BMI) and MMSE scores, were
used to adjust the latent variables’ indicators and hence
the latent constructs themselves (see Tables 1 and 2 for
description of items and covariates). Ps and Pd were vali-
dated by simultaneously regressing them onto 36 clinical
outcomes in separate multivariate regression models.
Both the latent variables’ indicators and the dependent
outcome variable of interest were adjusted for all seven
covariates. Bonferonni correction was used to adjust for
multiple comparisons with a p value of 0.002 considered
statistically significant. Mutlivariate normality was assessed
using Mardia’s coefficient [22].
Missing data: AMOS uses Full Information Maximum
Likelihood (FIML) methods to address missing data.
FIML uses the entire observed data matrix to estimate
parameters with missing data. In contrast to list-wise or
pair-wise deletion, FIML yields unbiased parameter esti-
mates and preserves the overall power of the analysis.
Along with multiple imputation approaches, FIML is
recommended as one of the best approaches to handling
missing data [23,24].
Fit Indices: The validity of structural models was
assessed using common fit indices. A non-significant
chi-square signifies that the data are consistent with the
model [25]. The comparative fit index (CFI), with values
ranging between 0 and 1, compares the specified model
with a model of no change [26]. CFI values below 0.95
suggest model misspecification. Values of 0.95 or greater
indicate adequate to excellent fit. A root mean square
error of approximation (RMSEA) of 0.05 or less indi-
cates a close fit to the data, with models below 0.05 con-
sidered “good” fit.” [27]. All three fit statistics should be
simultaneously considered to assess the adequacy of the
models to the data.
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Table 1 presents the data used to construct the latent
variables. 527 respondents (48.9%) endorsed pain in
the last month. 256 (23.8%) reported “some” and 190
(17.6%) reported “a lot” of pain-related functional limita-
tions. 456 (42.3%) reported seeking medical treatment
for pain. 402 (37.3%) reporting taking one or more pre-
scribed pain medications (mean 0.37 ± 0.56). 188 (17.4%)
reported “some” pain-related sleep disturbances. 81
(7.5%) reported “a lot”.
Table 3 presents the base SEM model’s regression co-
efficients. Also shown are the coefficients of the associ-
ation between the model indicators and covariates. The
assumption of multivaraite normality was not met in this
data sample, we therefore utilized a bootstrap method to
obtain unbiased estimates and standard errors. All indi-
cators loaded significantly on Pd and Ps, independently
of the covariates. Only Pd was allowed to be indicated
by CES-D scores (loading = 0.33, p ≤0.001). Ps was most
strongly loaded by self-reported pain-related physician
visits (PMD) (r = 0.48, p ≤0.001). Pd was most strongly
loaded by self-reported pain-related sleep disturbances
(PSLP) (r = 0.65, p <0.001). Ps was least strongly loaded
by PSLP (r = 0.23, p = 0.006).
This two factor model demonstrated far better fit
[χ2 = 20.4 (df = 12, p = 0.06); CFI = 0.998; RMSEA =
0.025] than a single factor model of pain items with de-
pression [χ2 = 126.5 (df = 16, p = 0.0001]; CFI = 0.975;
RMSEA = 0.08). The two factors are orthogonal by design.
Table 4 presents the results of several multivariate re-
gression models of selected clinical outcomes. Pd alone
was significantly independently associated with self-rated
health and life satisfaction. Both Pd and Ps were signifi-
cantly independently associated with chronic pain (> one
month), regional pain, and pain summed across selected
regions. Both were significantly and independently asso-
ciated with a history of arthritis, whether reported by
the respondent or confirmed by the informant.
Pd was associated with a self-reported h/o cancer, but
neither construct was associated with an informant con-
firmed history of that condition. Similarly, Pd was asso-
ciated with self-reported falls, and a self-reported fear
of falling, but neither construct was associated with
informant confirmed falls.
Pd was associated with a variety of sleep-related dis-
turbances, including frequent wakening, early wakening,
daytime fatigue, and summed total sleep disturbances.
Ps was not associated independently with any sleep dis-
turbance. Neither construct was associated with the abi-
lity to successfully complete five chair stands. However,
Pd was associated with failure to attempt chair stands.
The use of opiates was uniquely associated with Pd
scores, the use of NSAIDS with Ps scores. Pd was as-
sociated with Life-space, nursing home placement, andinformant ratings of stubbornness and sadness. Ps was
not associated with any of these four outcomes. Neither
construct was associated with declaration of a resuscitation
preference, mode of resuscitation preference declaration,
or with opting for a “Do Not Resuscitate” (DNR) order.
Most of the significant effects were modest and
added < 20% of additional variance to the model. However,
Pd’s associations with self-rated health, sleep disorders, and
life satisfaction were exceptionally strong.
Discussion
This analysis illustrates the potential of latent variables
to parse observed data into “unbiased” constructs with
unique predictive profiles. The latent constructs, by def-
inition, are unbiased by measurement error that affects
any subset of their indicators. Such error is “residual” to
the latent variable(s) of interest. However, latent con-
structs do have quantifiable statistical error parameters,
and are not technically “error free”.
Huber et al. [28] have previously attempted to build a
comprehensive model of pain processing in an SEM for-
mat. Our approach differs subtly from theirs in that it
effectively parses the variance into target-related and un-
related fractions. This is a methodological advance. The
resulting models have improved fit, and fewer intercor-
related residuals. The resulting latent variables are or-
thogonal to each other and, like their dementia-related
counterparts [7] can be output as continuously varying
subjective “pain” phenotypes. Our method could easily
be adapted for the extraction of a more comprehensive
set of latent constructs had such measures been available.
However, we were constrained by H-EPESE’s psychometric
battery, which did not include anxiety or other relevant
mood states.
Our analysis provides face and discriminant validity
for the modeled constructs. Ps was uniquely associ-
ated with NSAID use. Pd was uniquely associated with
informant-rated dysphoria, self-reported anxiety, and self-
reported sleep disturbances that are indicative of depressive
illness (e.g., early morning wakening).
Pd’s unique association with a broad range of self-
reported sleep disturbances was striking. Insomnia is a
risk factor for incident depression [29,30] and both sleep
disturbance and depressive symptoms are frequently re-
ported in musculoskeletal pain syndromes [31-33]. This
suggests that the report of pain-related sleep distur-
bances should prompt a careful review of depressive symp-
toms and may warrant anti-depressant therapy.
Pd is most strongly indicated by PMED, suggesting
either that drug seeking may be related to depressive
symptoms [34] or that the depressive component of self-
reported pain may be iatrogenic. It has been suggested
that persons with lower education and minorities, inclu-
ding Hispanics, are less likely to use mental healthcare
Table 3 Base SEM model parameters with covariates
Estimate S.E. p Standardized estimate
Pd Loadings
CES-D <−−− Pd 2.999 0.339 <0.001 0.327
PADL <−−− Pd 0.447 0.038 <0.001 0.580
PMD <−−− Pd 0.137 0.033 <0.001 0.277
PMED <−−− Pd 0.087 0.024 <0.001 0.180
PSLP <−−− Pd 0.396 0.031 <0.001 0.650
Ps Loadings
PADL <−−− Ps 0.191 0.060 0.001 0.248
PMD <−−− Ps 0.239 0.048 <0.001 0.483
PMED <−−− Ps 0.171 0.035 <0.001 0.354
PSLP <−−− Ps 0.137 0.050 0.006 0.225
Covariate Associations
CES-D <−−− Age −0.060 0.071 0.398 −0.026
PADL <−−− Age −0.003 0.005 0.595 −0.014
PMD <−−− Age −0.002 0.003 0.509 −0.016
PMED <−−− Age −0.001 0.002 0.512 −0.012
PSLP <−−− Age −0.008 0.005 0.076 −0.054
CES-D <−−− BMI −0.017 0.054 0.746 −0.011
PADL <−−− BMI 0.008 0.004 0.043 0.056
PMD <−−− BMI 0.002 0.002 0.395 0.022
PMED <−−− BMI 0.002 0.002 0.143 0.028
PSLP <−−− BMI 0.008 0.004 0.020 0.076
CES-D <−−− Gender 2.811 0.573 <0.001 0.146
PADL <−−− Gender −0.006 0.039 0.888 −0.003
PMD <−−− Gender −0.027 0.024 0.257 −0.026
PMED <−−− Gender 0.019 0.017 0.278 0.018
PSLP <−−− Gender 0.037 0.037 0.313 0.029
CES-D <−−− Income 0.345 0.754 0.647 0.015
PADL <−−− Income 0.050 0.051 0.331 0.026
PMD <−−− Income 0.012 0.031 0.694 0.010
PMED <−−− Income 0.017 0.022 0.441 0.014
PSLP <−−− Income 0.119 0.048 0.013 0.078
CES-D <−−− Live alone 1.698 0.599 0.005 0.085
PADL <−−− Live alone 0.033 0.041 0.426 0.019
PMD <−−− Live alone 0.041 0.025 0.098 0.038
PMED <−−− Live alone 0.018 0.018 0.321 0.017
PSLP <−−− Live alone 0.014 0.038 0.712 0.011
CES-D <−−− MMSE −0.446 0.048 <0.001 −0.290
PADL <−−− MMSE −0.014 0.003 <0.001 −0.110
PMED <−−− MMSE −0.003 0.001 0.042 −0.037
PMD <−−− MMSE −0.001 0.002 0.483 −0.017
PSLP <−−− MMSE −0.002 0.003 0.577 −0.017
CES-D <−−− NpainRx 2.539 0.484 <0.001 0.155
PADL <−−− NpainRx 0.823 0.033 <0.001 0.599
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Table 3 Base SEM model parameters with covariates (Continued)
PMD <−−− NpainRx 0.591 0.020 <0.001 0.671
PMED <−−− NpainRx 0.715 0.014 <0.001 0.832
PSLP <−−− NpainRx 0.372 0.031 <0.001 0.343
Model fit: χ2 = 20.4 (df = 12, p = 0.06); CFI = 0.998; RMSEA = 0.025.
Alone = living alone; BMI = calculated body mass index; CES-D = Centers for Epidemiological Studies-Depression scale; Income = informant assessment of monthly
income adequacy; MMSE = Mini-Mental State Exam; NpainRx = number of prescribed pain medications; PADL = self-reported pain-related functional limitations;
Pd = depression-related pain report; PMD = self-reported pain-related doctor visits; PMED = self-reported pain-related medication use; Ps = somatic-related pain
report; PSLP = self-reported pain-related sleep disturbance.
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disorders in the medical healthcare system [35,36]. On the
other hand, Pd was uniquely significantly associated with
opiate use. Post-operative depressive symptoms are a
stronger predictor of long-term post operative opiate use
than is the severity of post-operative pain [37], and a frac-
tion of those who receive opiates might benefit from anti-
depressant intervention, in conjunction with, but possibly
instead of opiate analgesics [38].
Pain is often cited as a risk factor for suicidal ideation
(SI). Unfortunately, SI is not assessed in H-EPESE, but
Pd was a unique predictor of self-rated QOL and health
status. Self-rated health and QOL are potent predictors
of mortality [39,40] as is major depression [41,42], sub-
syndromal depressive symptoms [43,44] and depressive
personality traits [45]. Pd could potentially mediate their
associations with mortality in H-EPESE [46].
It has been reported that pain increases the odds of re-
fusing DNR orders [47]. However, we did not confirm
this. The failure of either Pd or Ps to predict DNR status
suggests that such advance directives may not derive
from pain-related considerations in community dwelling
Hispanics [48]. Similarly, we did not find strong associa-
tions between these constructs and informant-rated agi-
tation, despite an established literature implicating pain
as a cause of behavioral agitation, particularly among
demented and institutionalized persons [49].
Depressive symptoms, even subsyndromal depressive
symptoms, are potent risk factors for future cognitive
decline, dementia conversion and institutionalization.
Similarly, Pd, but not Ps, was significantly associated
with life space, nursing home placement, and inform-
ant ratings of resistiveness, an institutionalization risk
factor. Since antidepressant treatment might be able to re-
duce Pd-related variance in self-reported pain, depressive
symptoms should be carefully screened in medical and re-
habilitation patients who are slated for institutionalization
following recovery from painful procedures [50,51].
Our model does not address potential cognitive deter-
minants of pain perception. H-EPESE has a limited cog-
nitive assessment, consisting only of the MMSE and
CLOX, an executive clock-drawing task [12]. CLOX
scores are not available from wave 7 at the time of this
analysis, and we chose instead to treat MMSE scores asa covariate. However, future analyses may be able to
construct a latent cognitive variable from these measures
(i.e., “Pc”). Then, the unique contributions of Pc, Pd and
Ps to these outcomes could be examined in similar multi-
variate models.
MMSE, CLOX scores and IADL ratings can also be
combined into a latent homolog of “d”, i.e., the cognitive
correlates of functional status [52]. d scores have been
mapped to elements of the DMN, which is dysfunctional
in both depression and Alzheimer’s Disease (AD) [1,52].
The significance of this is that the DMN is involved in
a variety of “self-referential” tasks [2] and deactivated
by painful visceral stimuli [53]. DMN dysfunction may
account for the notable “anosagnosia” seen in AD cases
[54]. Anosagnosia refers to diminished insight, and is
possibly relevant to a broad range of self-reported men-
tal states, including both depression and pain [55]. Thus,
both Ps and Pd may be vulnerable to assessment bias in
the setting of DMN-related disorders. This may explain
the often noted discrepancy between the pain self-
reports of demented persons and their comportment.
The DMN is hyperactive in depression [4] and may lead
to overestimates of painful stimuli. SEM models offer
the potential to adjust pain reports for inter-individual
variability in d and by extension, DMN structure.
We were limited in this analysis to categorical and
often dichotomously rated pain indicators. Future models
could be built from more normally distributed pain rat-
ings, ideally from validated pain assessment scales. The
resulting latent variables would be more normally dis-
tributed, which would then allow us to associate them
with potential biomarkers, using powerful parametric
statistical methods. The necessary observed variables
could be obtained by clinicians in the field, or over the
phone. Pd and Ps scores could then be generated in the
field by web or phone-based applications running multi-
variate regression classification models. Future studies
might then use these phenotypes as outcome measures
in clinical pain management trials. If we could demon-
strate specific treatment effects of analgesic, antidepres-
sant or cognitive enhancing therapies on Ps, Pd (and
potentially Pc) respectively, then treatment decisions
could be individualized on the basis of an individual’s Ps,
Pd and Pc scores.













1 Chronic pain 0.25 ≤0.001 0.32 ≤0.001 0.30 0.02
2 Pain “all over” −0.32 ≤0.001 0.11 0.04 0.19 0.08
3 Legs −0.35 ≤0.001 0.24 ≤0.001 0.40 0.22
4 Feet −0.25 ≤0.001 0.16 0.006 0.26 0.18
5 Knees −0.33 ≤0.001 0.22 ≤0.001 0.38 0.22
6 Hip −0.29 ≤0.001 0.12 0.02 0.24 0.14
7 Back −0.22 ≤0.001 −0.20 ≤0.001 0.25 0.16
8 Summed pain −0.42 ≤0.001 0.25 ≤0.001 0.58 0.34
9 Alzheimer’s (r) −0.07 0.107 −0.16 ≤0.001 0.06 0.03
10 Cancer (r) 0.19 ≤0.001 −0.05 0.38 0.16 0.11
11 Arthritis (r) −0.16 ≤0.001 0.15 0.001 0.14 0.09
12 CA (i) 0.03 0.42 0.02 0.67 0.01 0.01
13 Arthritis (i) −0.10 0.03 0.15 0.002 0.10 0.07
14 Both (i) −0.09 0.04 0.12 0.02 0.07 0.05
15 Opiate use −0.014 ≤0.001 0.06 0.17 0.25 0.23
16 NSAID use 0.05 0.20 0.09 0.03 0.03 0.02
17 Health −0.38 ≤0.001 0.02 0.76 0.20 0.05
18 QOL −0.47 ≤0.001 0.00 0.99 0.25 0.02
19 Life Space 0.10 0.02 0.04 0.32 0.09 0.07
20 Sleep Disturbances (Total) 0.55 ≤0.001 0.02 0.71 0.33 0.03
21 Early wakening −0.36 ≤0.001 0.07 0.19 0.18 0.05
22 Frequent wakening −0.17 ≤0.001 0.11 0.02 0.07 0.03
23 Feeling tired −0.44 ≤0.001 0.10 0.07 0.27 0.06
24 Agitation (summed) −0.19 ≤0.001 0.01 0.88 0.05 0.01
25 NPI Nighttime agitation −0.17 ≤0.001 0.02 0.68 0.04 0.01
26 NPI restless −0.05 0.23 0.01 0.88 0.00 0.00
27 NPI impatient −0.05 0.19 0.00 0.95 0.02 0.02
28 NPI Δ weight −0.08 0.06 0.02 0.62 0.02 0.01
29 NPI resistive −0.09 0.03 0.03 0.54 0.04 0.03
30 NPI sad −0.18 ≤0.001 0.01 0.77 0.06 0.02
31 5 chair stands 0.03 0.58 0.08 0.14 0.04 0.03
32 Stands safely 0.19 ≤0.001 −0.05 0.38 0.16 0.11
33 Falls (i) −0.07 0.11 −0.02 0.71 0.02 0.01
34 Falls (r) −0.32 ≤0.001 0.00 0.99 0.19 0.09
35 Fear of falling −0.29 ≤0.001 0.00 0.97 0.16 0.08
36 Nursing Home −0.08 0.04 −0.07 0.12 0.02 0.01
37 DNR declaration 0.02 0.66 0.04 0.43 0.01 0.01
38 DNR mode 0.00 0.93 0.01 0.83 0.01 0.01
39 DNR 0.03 0.53 0.05 0.40 0.01 0.00
Pd = Depression related pain independent predictor variable; Ps = Somatic related pain independent predictor variable; Number of pain medications (NPainmeds);
Model Covariates: Live alone, age, gender, BMI, Income, MMSE; CA = cancer; DNR = Do Not Resusitate order; (i) = informant rated; NPI = Neuropsychiatric Inventory;
NSAID = non-steriodal anti-inflammatory agents; QOL = quality of life; (r) = respondant rated.
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http://www.hqlo.com/content/12/1/13In summary, a latent variable approach to pain assess-
ment offers an alternative to demonstrably biased self-
reported pain assessment. The latent variables Pd and Ps
can be constructed in many existing datasets, from ad
hoc combinations of pain and depressive symptom rat-
ings. This can allow high quality pain assessments to be
made retrospectively in existing datasets or prospectively
in minority or rural populations, far from tertiary care
centers. Furthermore, Pd and Ps scores represent con-
tinuously varying pain phenotypes that can be associated
with potential bio-markers, or used as outcomes mea-
sures in clinical trials. This may help individualize pain
management regimens, especially in minority, rural or
cognitively disadvantaged patients.
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